(Q36779439)

16 August 2017

1 reference

title

Drugs of abuse and the aging brain (English)

1 reference

16 August 2017

Gayathri J Dowling

1

1 reference

16 August 2017

Susan R B Weiss

series ordinal

2

1 reference

16 August 2017

Timothy P Condon

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

4 April 2007

1 reference

16 August 2017

published in

Neuropsychopharmacology

1 reference

16 August 2017

volume

33

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

209-218

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301412

16 August 2017

exact match

0 references

cites work

A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Alcohol use in retirement communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Epidemiology of problem drinking among elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Alcohol abuse in elderly emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Marginality among older injectors in today's illicit drug culture: assessing the impact of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Effect of aging in human cortical pre- and postsynaptic serotonin binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

The therapeutic potential of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

Free radicals and aging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Brain maturation may be arrested in chronic cocaine addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Brain 5-HT2 receptor binding sites in depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Projecting drug use among aging baby boomers in 2020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Therapeutic potential of cannabinoids in CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Is a fall just a fall: correlates of falling in healthy older persons. The Health, Aging and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Substance abuse in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Inhibition of monoamine oxidase B in the brains of smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Cardiovascular manifestations of substance abuse part 1: cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Inflammatory response in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Assessing a vigilance decrement in aged rats: effects of pre-feeding, task manipulation, and psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

The therapeutic potential of the cannabinoids in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Cannabinoids and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Use of inappropriate prescription drugs by older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Marked disparity between age‐related changes in dopamine and other presynaptic dopaminergic markers in human striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Substance use disorders in a geriatric psychiatry outpatient clinic: prevalence and epidemiologic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Drug treatment careers. A conceptual framework and existing research findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

A 33-year follow-up of narcotics addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Effects of age on tissues and regions of the cerebrum and cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Effects of morphine on brain-stimulation reward thresholds in young and aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Herbal products and other supplements: use by elderly veterans with depression and dementia and their caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

The effect of age-related factors on behavior induced by cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Increased sensitization to morphine-induced oral stereotypy in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Effects of ageing on serotonin transporters in healthy females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Outcomes at 1 and 5 years for older patients with alcohol use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Effect of age on human brain serotonin (S-1) binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Aging and Extrapyramidal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Assessment and treatment of alcoholism and substance-related disorders in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Alcohol and drug dependence among the elderly: epidemiology, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Drug therapy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

The potential impact of the baby-boom generation on substance abuse among elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Smoking, nicotine and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Ageing and the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Age-dependent decline in human brain dopamine D1 and D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Factors associated with illegal drug use among older methadone clients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

The elderly and the use of illicit drugs: sociological and epidemiological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Change in the pattern of illegal drug use in an inner city population over 50: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Cognitive-behavioral treatment of older veterans with substance abuse problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Glutamatergic neurotransmission in aging: a critical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Elevated density of [3H]imipramine binding in aged human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Mapping cortical change across the human life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Aging and Alzheimer's disease. Altered cortical serotonergic binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Decreased dopamine transporters with age in health human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

The risk for mild kidney function decline associated with illicit drug use among hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Cocaine abusers do not show loss of dopamine transporters with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Age-dependent decline of dopamine D1 receptors in human brain: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Diabetic ketoacidosis associated with cocaine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Geriatric patients on a substance abuse consultation service

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Unrecognized drug dependence in psychiatrically hospitalized elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

The effects of stimulant drugs on information processing in elderly adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Neuroprotective Antioxidants from Marijuanaa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Is correction for age necessary in neuroimaging studies of the central serotonin transporter?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Aging alters amphetamine-induced stereotyped gnawing and neostriatal elimination of amphetamine in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Screening for drug and alcohol abuse among older adults using a modified version of the CAGE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Recreational drug use: a neglected risk factor for end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Modifiable risk factors predict functional decline among older women: a prospectively validated clinical prediction tool. The Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Over-the-counter medication use in an older rural community: the MoVIES Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

3H-amphetamine concentrations in the brains of young and aged rats: implications for assessment of drug effects in aged animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Decreases in behavioral and striatal neuronal responses to dexamphetamine with aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301412

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301412

1 reference

Dimensions Publication ID

16 August 2017

1011147216

0 references

1 reference